Hackensack Meridian Health Earns First U.S. Joint Commission AI Certification

Hackensack Meridian Health (HMH) has become the first healthcare network in the United States to receive the Responsible Use of AI in Healthcare (RUAIH) Certification from The Joint Commission. The milestone establishes a new benchmark for how large-scale medical providers integrate artificial intelligence into clinical operations while maintaining strict ethical standards.

The certification follows a rigorous evaluation by The Joint Commission, an independent nonprofit, which assessed the network's approach to AI governance, patient privacy safeguards, and staff training protocols. The RUAIH program is a voluntary initiative designed to ensure that AI tools are implemented with transparency and a focus on risk mitigation. As part of its digital strategy, HMH utilizes technology from AI company Hyro to support its operations.

The Push for Standardized Oversight

The adoption of AI in medicine has accelerated as health systems seek to improve clinical decision-making and alleviate the administrative burdens that often lead to provider exhaustion. However, the rapid rollout of these technologies has created an urgent need for standardized oversight to prevent algorithmic bias and ensure patient safety. The Joint Commission developed the RUAIH framework to provide a structured path for the responsible adoption of these tools, moving beyond internal guidelines to a third-party verified standard.

Implications for the Industry

By securing this certification, HMH is positioning itself as a blueprint for other healthcare providers navigating the tension between innovation and safety. The network aims to use AI to enhance the capabilities of its medical staff rather than replace them. Robert C. Garrett, CEO of Hackensack Meridian Health, noted that AI has the potential to help clinicians detect diseases earlier, personalize patient treatment, and reduce the administrative workload that contributes to burnout.

This shift toward certified AI governance suggests that the industry is moving toward a period of increased regulation and accountability. By establishing rigorous safeguards, health systems can potentially improve patient outcomes while ensuring that the human element of medicine remains central to care delivery. Joel Klein, M.D., executive vice president and chief digital and information officer at HMH, emphasized that the goal of AI is not to replace the human side of medicine, but to strengthen it.

Future Outlook

Industry observers will now watch to see if other major health systems pursue the RUAIH Certification to validate their own AI frameworks. As more providers adopt these tools, the focus is expected to shift toward long-term performance monitoring and the continuous reduction of bias in clinical algorithms. While HMH has set the initial precedent, the broader impact of this certification will depend on how widely the RUAIH standards are adopted across the national healthcare landscape.